Suchen
Abeona Therapeutics Inc
ABEOZur Watchlist hinzufügen
5.430USD
-0.100-1.81%
Handelsschluss 09-24 16:00（ET）
309.51MMarktkapitalisierung
4.24KGV TTM
Über Abeona Therapeutics Inc Unternehmen
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. The Company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa. Its fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio serves as the manufacturing site for ZEVASKYN commercial production. Its development portfolio features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. Its AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases. Its pipeline programs include ABO-504 (Stargardt disease), ABO-503 (X-linked retinoschisis), ABO-505 (autosomal dominant optic atrophy), UX111 (Sanfilippo Syndrome Type A (MPS IIIA)), TSHA-102 (Rett Syndrome), and TSHA-118 (Infantile Batten Disease (CLN1 Disease)).
Abeona Therapeutics Inc Profil
BörsenkürzelABEO
Name des UnternehmensAbeona Therapeutics Inc
IPO-datumSep 19, 1980
CEOSeshadri (Vishwas)
Anzahl der mitarbeiter136
WertpapierartOrdinary Share
GeschäftsjahresendeSep 19
Addresse6555 Carnegie Ave, 4th Floor
StadtCLEVELAND
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl44103
Telefon16468134701
Websitehttps://abeonatherapeutics.com/
BörsenkürzelABEO
IPO-datumSep 19, 1980
CEOSeshadri (Vishwas)
Führungskräfte von Abeona Therapeutics Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Madhav Vasanthavada, Ph.D.
Dr. Madhav Vasanthavada, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
290.62K
-4.34%
Dr. Madhav Vasanthavada, Ph.D.
Dr. Madhav Vasanthavada, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
290.62K
-4.34%
Dr. Madhav Vasanthavada, Ph.D.
Dr. Madhav Vasanthavada, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
290.62K
-4.34%
Mr. Michael Amoroso
Mr. Michael Amoroso
Chairman of the Board
Chairman of the Board
217.78K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Vishwas (Vish) Seshadri, Ph.D.
Dr. Vishwas (Vish) Seshadri, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.31M
-5.20%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Dr. Brendan O'Malley, J.D., Ph.D.
Dr. Brendan O'Malley, J.D., Ph.D.
Chief Legal Officer
Chief Legal Officer
427.95K
-2.82%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Abeona Therapeutics Inc?
Die fünf größten Anteilseigner von Abeona Therapeutics Inc sind: Dr. Vishwas (Vish) Seshadri, Ph.D.
Wie viele Institutionen halten Anteile an Abeona Therapeutics Inc (ABEO)?
Mit Stand vom 2026Q1 halten 221 Institutionen Anteile an Abeona Therapeutics Inc, mit einem Gesamtmarktwert von etwa 40.30M, was 70.85% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -6739269.00 gestiegen.